Following A -2.50% Weekly Decline, Is It Still A Buy For Tempest Therapeutics Inc (NASDAQ: TPST)?
Tempest Therapeutics Inc (NASDAQ:TPST)’s traded shares stood at 0.48 million during the last session, with the company’s beta value hitting -1.67. At the close of